Page last updated: 2024-11-05

propyleneimine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6377
CHEMBL ID3183775
CHEBI ID82340
MeSH IDM0098036

Synonyms (58)

Synonym
propylenimine
nsc20655
propyleneimine
75-55-8
1,2-propyleneimine
methylaziridine
nsc-20655
1,2-propylenimine
2-methylaziridine
methylethylenimine
wln: t3mtj b1
2-methylazacyclopropane
2-methylethylenimine
aziridine, 2-methyl-
propyleneimine, inhibited
rcra waste no. p067
rcra waste number p067
2-methyl aziridine
hsdb 739
propylene imine
einecs 200-878-7
ai3-50325
brn 0102386
un1921
nsc 20655
propilenimina [spanish]
ccris 539
2-methylaziridine, technical grade, 90%
inchi=1/c3h7n/c1-3-2-4-3/h3-4h,2h2,1h3
ozdgmoyksfplse-uhfffaoysa-
AKOS005366679
s-2-methylaziridine
C19257
dtxsid8024286 ,
tox21_202944
NCGC00260490-01
dtxcid604286
cas-75-55-8
STL168051
propilenimina
ulc972q7tz ,
5-20-01-00150 (beilstein handbook reference)
propyleneimine, inhibited [un1921] [flammable liquid]
unii-ulc972q7tz
ec 200-878-7
dl-2-methylaziridine
FT-0649217
2-methylaziridine [iarc]
propyleneimine [hsdb]
2-methylaziridine, (+/-)-
aziridine, 2-methyl-, (2s)-
CHEBI:82340 ,
un 1921 (salt/mix)
CHEMBL3183775
Q7250470
2-methylaziridine (propylenimine)
2-?methylaziridine (propylenimine)
(r)-2-methylaziridine, 1m in toluene

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Evidence is presented that propyleneimine exerts its early toxic effect on the renal papilla."( Renal toxicity of propyleneimine: assessment by non-invasive techniques in the rat.
Fowler, JS; Halman, J; Miller, J; Price, RG, 1986
)
0.9

Dosage Studied

ExcerptRelevanceReference
" Urine was collected for up to 48 hr after dosing and was analyzed by 1H NMR spectroscopy (400 MHz) and conventional biochemical methods to provide biochemical fingerprints of urine in various site-specific nephrotoxic states."( Investigations into the biochemical effects of region-specific nephrotoxins.
Bonner, FW; Gartland, KP; Nicholson, JK, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aziridines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.48270.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency17.22890.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.81)18.7374
1990's10 (27.03)18.2507
2000's12 (32.43)29.6817
2010's10 (27.03)24.3611
2020's1 (2.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.08 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index40.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.56%)4.05%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]